Viewing Study NCT01218204


Ignite Creation Date: 2025-12-24 @ 9:10 PM
Ignite Modification Date: 2026-05-24 @ 12:00 PM
Study NCT ID: NCT01218204
Status: COMPLETED
Last Update Posted: 2019-07-16
First Post: 2010-09-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dyslipidaemias View
None Dyslipidemias View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pharmacodynamics View
None Lipids View
None Dyslipidemia View
None Safety View
None GSK1292263 View
None Ezetimibe View
None Statin View
None Pharmacokinetics View
None Tolerability View
None Atorvastatin View